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Abstract
Background: Today, patients often expect to achieve spectacle independance after cataract surgery. New trifocal
intraocular lenses have been developed to try and fullfill this demand. The purpose of this study is to report the
short-term visual outcomes of a new trifocal intraocular lens (AcrySof PanOptix™).
Methods: Consecutive adult patients undergoing cataract surgery with bilateral implantation of the study
intraocular lens in a private practice clinic were considered for inclusion. Exclusion criteria were the presence of
other ocular pathologies or preoperative astigmatism >1.5 diopters (D). Patients with intraoperative complications
were excluded from analysis. One month after surgery patients underwent: monocular defocus curve; monocular
and binocular uncorrected visual acuity in photopic and mesopic conditions, for far (4 m), intermediate (60 cm) and
near (33 cm) distances and binocular contrast sensitivity. Patients completed a visual satisfaction questionnaire
between 9 and 12 months after surgery.
Results: One hundred and sixteen eyes of fifty-eight patients receiving bilateral implantation of the study
intraocular lens were analysed. Mean binocular uncorrected visual acuity in photopic conditions was 0.03
LogMAR for far, 0.12 for intermediate and 0.02 for near distances. All patients achieved a binocular uncorrected
visual acuity better than 0.3 LogMAR (20/40 Snellen equivalent) for distance and near vision and 94.8% of
patients for intermediate vision. Mesopic binocular uncorrected visual acuity values were similar to photopic
values. The monocular defocus curves showed that the best visual acuity was reached at a vergence of 0.00D.
Visual acuity dropped slightly at −1.00D and peaked again at −2.00D. Visual acuities better than 0.2 LogMAR
were maintained between −2.50D and +0.50D. Contrast sensitivity was high and similar in photopic and mesopic
conditions. As regards patient-evaluated outcomes, only 2 patients (3.4%) were fairly dissatisfied with their sight
after surgery. Three patients (5.1%) reported the need for spectacle correction for certain activities. All other
patients (94.8%) reported never using spectacle correction.
Conclusions: The PanOptix trifocal IOL provides good short-term visual outcomes, with good intermediate
performance and excellent patient-reported satisfaction. The similar values achieved in mesopic and photopic
conditions in binocular uncorrected visual acuity and contrast sensitivity suggest low pupillary dependence for
light distribution.
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Background
Intraocular lens (IOL) design is continuously evolving
in order to improve visual outcomes, increase patient
satisfaction and achieve spectacle-independence after
cataract surgery. Diffractive bifocal IOLs were designed
with concentric rings which create a near and far focus;
pupillary changes help to adjust light distribution be-
tween both focuses to improve visual function [1]. A
drawback of bifocal IOLs is that intermediate perform-
ance is often below the requirements for activities such
as computer use or correct dashboard perception while
driving [2, 3]. Trifocal technology has been developed
to create a true intermediate focus to overcome these
difficulties. Initial reports on the visual outcomes of the
FineVision® (Physiol, Liège, Belgium) and AT LISA
tri839MP® (Carl Zeiss Meditec, Jena, Germany) trifocal
IOLs are encouraging [4–12].
The new AcrySof PanOptix® trifocal IOL (Alcon Re-
search, Fort Worth, TX, USA) has been developed to
improve light transmission and distribution between
the three focuses. Its design aims to decrease pupillary
dependence for excellent performance and to improve
intermediate vision. To the best of our knowledge, so
far there have been no reports on daily practice clinical
outcomes with this new trifocal IOL. The purpose of
this study was to evaluate clinical outcomes in patients
with bilateral PanOptix lens implantation.
Methods
This study was a prospective case series evaluating visual
function in patients scheduled for bilateral implantation
of the studied IOL. The study adhered to the tenets of
the declaration of Helsinki and was approved by the
ethics committee of the Hospital Clínico San Carlos,
Madrid. Inclusion criteria were patients over 18 years
old candidates for bilateral cataract surgery. Exclusion
criteria were the presence of any ocular pathology
which could compromise visual recovery, preoperative
astigmatism higher than 1.5 Diopters (D) on corneal
topography or abnormal iris.
Candidates for cataract surgery underwent an exten-
sive evaluation including: best-corrected visual acuity
(BCVA), anterior segment biomicroscopic evaluation,
intraocular pressure measurement, corneal topography
(Pentacam HR model 70,900, Oculus, Germany), specu-
lar biomicroscopy (CEM-530, NIDEK CO, LDT, Japan),
dilated fundus examination, optical coherence tomog-
raphy examination of the macula and optic nerve (Cirrus
HD-OCT 5000, Carl Zeiss Meditec AG, Germany) and
IOL calculation with the IOL Master 700 (Carl Zeiss
Meditec AG, Germany). After these explorations and an
in-depth discussion of the characteristics of monofocal
and multifocal lens, the ophthalmologist recommended
the intraocular lens best suited to the patient. If the
recommended lens was the Panoptix IOL, the patient
was considered for inclusion in the study. The purpose
of the study was explained to patients with none of the
exclusion criteria and patients agreeing to participate
signed an informed written consent.
Surgery was scheduled first for the eye with the worst
visual acuity. The other eye underwent surgery between
one and 10 days later. Patients were seen on the day
after the intervention and between 30 and 40 days (1-
month visit) after the second procedure. Patients with
any intraoperative or postoperative complications were
excluded from analysis. At the 1-month visit, all explo-
rations performed preoperatively were repeated. In
addition, the following specific explorations of the
study were performed at the 1-month visit. Patients
underwent: monocular defocus curve; mono- and bin-
ocular uncorrected visual acuity in photopic and meso-
pic conditions, for far, intermediate and near distances;
subjective refraction and binocular contrast sensitivity
in photopic and mesopic conditions.
For photopic visual acuity measurements, room lumi-
nance was 85 cd [cd]/m2. Monocular and binocular un-
corrected distance visual acuity were measured using a
22″ LED liquid crystal display system (CC-100 HW 5.0
Series, Topcon) that can display ETDRS charts at 4 m.
Monocular and binocular uncorrected near visual acu-
ity were measured using the Logarithmic Visual Acuity
Chart 2000 New ETDRS (Precision Vision, Lasalle, IL)
at 33 cm. Intermediate visual acuity was also assessed
both mono- and binocularly, at 60 cm.
Subjective refraction was performed with the ETDRS
chart at 4 m. The defocus curve was then performed mon-
ocularly with the patients observing the ETDRS chart
through lenses starting at −5.00 D and increasing in 0.50
D steps to +3.00 D. Binocular contrast sensitivity was
measured at spatial frequencies of 3, 6, 12, and 18 cycles
per degree (cpd) using the functional acuity contrast test
(Test SV-1000) of the CC-100 HW 5.0 Series system.
After dark adaptation (10 min in the testing room
under mesopic conditions), mesopic monocular and bin-
ocular uncorrected distance visual acuity were measured
with the room luminance set to 3 cd/m2. Mono- and
binocular near and intermediate visual acuity were also
measured in mesopic conditions, as well as binocular
contrast sensitivity. Absolute log10 contrast sensitivity
(log10 CS) values were obtained and the mean values
and standard deviations were calculated.
Between 9 and 12 months after surgery the patients
were contacted and asked to fulfill the Catquest 9-SF
questionnaire, which has been recently validated in a
Spanish population [13]. Since this questionnaire does
not specifically ask about certain issues that are important
when evaluating the outcomes of trifocal IOLs, five other
questions were added to the questionnaire (Table 1).
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Intraocular lens
The PanOptix IOL is a single-piece, aspheric, non-
apodized diffractive IOL with a 6.0-mm biconvex optic,
an overall diameter of 13.0 mm, and 0-degree haptic
angulation. It has a central trifocal zone of 4.5 mm, de-
signed to reduce pupillary dependence (Fig. 1). For a
pupil diameter of 3 mm, it transmits 88% of incident
light with an asymmetric distribution of 50% to the
distance focus and 25% for the intermediate and near
foci. It has an addition of +3.25 D for the near focus
and a + 2.17 D addition for the intermediate focus at
the IOL plane.
Statistics
Statistics were performed with the SPSS Advanced Stat-
istical 20.0 software (SPSS, Inc., Chicago, IL). Quantita-
tive data are provided as ranges, means and standard
deviations (SD). The Student t-test was used to com-
pare normally distributed data as confirmed using the
Kolmogorov-Smirnov test, and non-parametric tests for
non-normally distributed data. Significance was set at a
p ≤ 0.05. P values provided are two-tailed.
Results
Sixty patients were initially included in the study. One
patient was excluded from analysis because at the 1
month visit he had postsurgical macular edema in one
eye. Another patient was excluded because there was a
posterior capsular tear during surgery, although a poster-
ior capsular rexis was performed and the IOL was finally
implanted in the bag. Therefore, fifty-eight patients were
included in the analysis, with 45 women (77.6%) and 13
Table 1 Questions added to the Catquest 9-SF questionnaire
with options provided
1. Do you use spectacle correction…
For near distance (for reading or sewing)?
Never
Sometimes
Always
For intermediate distance (using computers or cooking)?
Never
Sometimes
Always
For far distances (driving, cinema)?
Never
Sometimes
Always
2. Do you see halos with low illumination (during the night or if there
is little light)?
Never
Occasionally
Often
Always
3. Do light sources provoke glare with low illumination (such as driving
at night)?
Never
Occasionally
Often
Always
4. Do you have difficulties when driving at night?
Never
Occasionally
Often
Always
5. Would you undergo the same surgery again?
Yes
No
Fig. 1 The PanOptix intraocular lens. It is a single-piece, aspheric,
non-apodized diffractive lens with a 6.0-mm biconvex optic, a
central trifocal zone of 4.5 mm, an overall diameter of 13.0 mm,
and 0-degree haptic angulation
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men (22.4%). Mean age was 69.3 years (standard deviation
[SD] 9.79 years), ranging between 43 and 85 years.
Visual acuity and refractive status
Table 2 records mono- and binocular uncorrected visual
acuity. There were no significant differences between the
values for photopic and mesopic conditions (p > 0.05 for
all comparisons). One month after surgery, all patients
achieved an uncorrected photopic binocular visual acuity
of 0.3 LogMAR (Snellen equivalent 20/40) or better for
far and near distances, with 96.6% achieving a distance
and 86.2% a near acuity of 0.1 LogMAR (Snellen
equivalent 20/25) or better (Fig. 2). For intermediate
distance, 56.9% of patients reached an uncorrected bin-
ocular acuity better than 0.1 and 37.9% were between
0.3 and 0.1. Only 5.2% didn’t reach an intermediate
acuity better than 0.3. Mesopic visual acuities were
similar to photopic values, with slightly lower percent-
ages of patients reaching 0.1.
Mean postoperative spherical equivalent was −0.10
D ± 0.26 (range − 0.87 to +0.75 D). Postoperative spher-
ical equivalent was between −0.50 and +0.50 D in 94.8%
of eyes, with 4.3% (5 eyes) between −1.00 and −0.50 D
and 0.9% (1 eye) between +0.50 and +1.00 D.
Defocus curve
Figure 3 shows the through-focus corrected monocular
logMAR visual acuity. The best visual acuity (0.02 [SD
0.06] and 0.01 [SD 0.05] for the right and left eyes) was
reached at a vergence of 0.00 D, corresponding to the far
focus. Visual acuity dropped slightly at −1.00 D, corre-
sponding to the intermediate focus and then peaked
again at −2.00 D (near focus). Visual acuities of 0.2 or
better were maintained between −2.50 and +0.50 D.
Contrast sensitivity
Figure 4 shows the mean binocular log10 CS values under
photopic (85 cd/m2) and mesopic (3 cd/m2) conditions.
Contrast sensitivity was similar in photopic and mesopic
conditions (p > 0.05 for all spatial frequencies).
Visual satisfaction questionnaire
On the Catquest 9-SF questionnaire, 49 patients (84.5%)
reported their vision caused them no difficulties in their
daily lives. Nine patients (15.5%) reported having some
difficulties. As regards their current vision, 32 patients
(55.2%) were very satisfied, 24 patients (41.4%) quite
satisfied and 2 patients (3.4%) quite unsatisfied. Of the
two unsatisfied patients, when further questioned, one
of them actually complained of tearing and itching and
not really of visual difficulties. Another had difficulties
due to posterior capsule opacification and was sched-
uled for YAG capsulotomy. Figure 5 shows the answers
to the other questions on the Catquest 9-SF question-
naire. More than 79% of patients reported having no
difficulties in performing all tasks.
As regards spectacle use, for near vision 56 patients
(96.6%) never used spectacles, one patient (1.7%) some-
times and another patient (1.7%) always. Only one pa-
tient (1.7%) reported using spectacles sometimes for
intermediate vision. One patient (1.7%) reported using
spectacle correction always for far vision, two patients
(3.4%) sometimes and 55 patients (94.8%) never. Figure
6 shows the patient’ reported incidence of halos and
glare and the difficulties for driving at night. Four pa-
tients reported they wouldn’t undergo the same surgery
again: three of them due to ocular surface problems
(tearing, itching, red eye). The other one was the patient
with posterior capsule opacification.
Discussion
Multifocal IOLs were developed to satisfy patients’
demands to be spectacle-independent after cataract
surgery. Although bifocal IOLs provided good visual
function for far and near distances, intermediate per-
formance often did not meet patients’ expectations.
Table 2 Full-contrast logMAR uncorrected visual acuity. Data are provided as the mean (standard deviation) and range
Right eye Left eye Binocular
Photopic
(85 cd/m2)
Far (4 m) 0.06 (0.090)
0.30 to −0.1
0.06 (0.078)
0.26 to −0.1
0.03 (0.046)
0.14 to −0.16
Intermediate (60 cm) 0.20 (0.182)
0.60 to −0.10
0.18 (0.145)
0.60 to −0.06
0.12 (0.143)
0.50 to −0.18
Near (33 cm) 0.08 (0.116)
0.40 to −0.12
0.07 (0.109)
0.32 to −0.16
0.02 (0.099)
0.30 to −0.18
Mesopic
(3 cd/m2)
Far (4 m) 0.06 (0.746)
0.26 to 0
0.05 (0.070)
0.28 to 0
0.03 (0.048)
0.24 to 0
Intermediate (60 cm) 0.21 (0.169)
0.64 to − 0.1
0.19 (0.152)
0.64 to − 0.1
0.12 (0.148)
0.5 to − 0.16
Near (33 cm) 0.09 (0.119)
0.40 to − 0.10
0.08 (0.124)
0.44 to − 0.16
0.03 (0.108)
0.26 to − 0.18
cd/m2 candelas per square meter, m meters, cm centimeters
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Trifocal technology has been developed to improve
intermediate visual function, which is necessary for ac-
tivities such as using laptops, smartphones and tablets,
playing cards, reading price tags or focusing on the
dashboard while driving. The PanOptix IOL has a novel
diffractive structure which would allow a higher light
utilization, transmitting 88% of light to the retina at a
simulated 3.0 mm pupil size. Bench Badal image testing
and modulation transfer measurements have shown
that the PanOptix is equivalent to bifocal IOLs in pho-
topic near and distance performance while providing a
substantial range of intermediate foci with an optimal
intermediate focus at 60 cm [14]. However, we are not
aware of reports of visual outcomes of the PanOptix in
daily clinical practice.
We performed this prospective observational study in
order to report the early results after cataract surgery
with bilateral implantation of the PanOptix. Visual per-
formance was evaluated 1 month after surgery because
previous studies have not found significant differences in
visual acuity one, three and 6 months after surgery in
patients receiving trifocal lens [4, 6, 7, 10, 15]. Similarly,
contrast sensitivity has also been found to be stable be-
tween 1 and 12 months postoperatively [9]. As regards the
distances at which intermediate and near visual acuity
were evaluated, studies performed with a reading desk
have reported that the preferred intermediate distance
ranges between 61.50 cm and 64.20 cm [14, 16]; 60 cm
was chosen because it is very similar to this preferred
range and has been already used in other publications
Fig. 2 LogMAR visual acuity distribution for uncorrected binocular visual acuity, for photopic (85 cd/m2) and mesopic conditions (3 cd/m2), for
far (4 m) intermediate (60 cm) and near (33 cm) distances
Fig. 3 Monocular distance-corrected defocus curve given in logMAR 1 month after surgery
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[4, 5, 15], facilitating comparison with studies performed
with other IOLs. Similarly, the mean reported preferred
near distance ranges between 34.6 cm and 38.70 cm
[14, 16] and 33 cm was chosen as the distance to evaluate
near vision as used in one other study which compared
two trifocal IOLs [15].
We found that the monocular and binocular uncor-
rected distance, intermediate and near visual acuities 1
month after binocular implantation of the PanOptix IOL
were high and similar to those described for other tri-
focal lens [4–6, 10, 12, 15, 17]. One of the concerns
about trifocal technology is that the light distribution to
create an intermediate focus might interfere with the far
and near focuses and reduce visual acuity. However, the
uncorrected distance and near vision achieved by our
patients were similar to other studies with bifocal lens
[2, 6, 18], suggesting that the addition of an intermediate
focus does not interfere with the other two focuses.
Comparisons with other studies describing trifocal
IOL visual outcomes are difficult because of the different
characteristics of the patients included and the different
methods for measuring visual acuity and contrast sensi-
tivity employed in each study (Table 3). Binocular uncor-
rected distance visual acuity was similar or slightly worse
in our study than reported for the AT LISA Tri, although
a higher percentage of patients achieved an uncorrected
binocular visual acuity better than 0.1 [4, 7, 19]. Binocular
uncorrected distance visual acuity was also slightly better
with the Finevision [5, 6, 15]. Intermediate visual acuity
was similar for the PanOptix (0.12 LogMAR) to the values
Fig. 4 Mean binocular contrast sensitivity function in photopic (85 cd/m2) and mesopic conditions (3 cd/m2) 1 month after surgery
Fig. 5 Patient’ answers to question 3 of the Catquest 9-SF questionnaire, which explores difficulties in performing different activities of daily life
García-Pérez et al. BMC Ophthalmology  (2017) 17:72 Page 6 of 9
reported for 60 cm for the AT LISA Tri (between 0.11 [4]
and 0.13 LogMAR [15]) and slightly worse than reported
for the FineVision (between 0.06 [5] and 0.03 LogMAR
[15]). Near acuity (0.02 LogMAR) was similar to that
reported for the FineVision (between 0.00 [5] and 0.02
LogMAR [15] for 30 to 33 cm) and better than reported
for the AT LISA (between 0.13 and 0.32 [4, 15]).
Defocus curves are usually performed binocularly in
order to replicate real life situations. Kretz et al. showed
that the effect of binocular fusion gave an average gain
of one line for all distances [19]. We performed
monocular defocus curves to determine the true range
of focus provided by the IOL per se, without the effect
of binocular summation. Defocus curves for bifocal IOLs
typically show two humps, corresponding to the visual
acuity peaks for the far (0.00D) and near (−2.50D) fo-
cuses, with decreased acuity for the intermediate range
(from-1.00 to −2.00D) [2, 18, 20]. The monocular de-
focus curves for the PanOptix in our study (Fig. 3)
showed two peaks, at 0 and −2.00D, but visual acuity
remained excellent in between, with a LogMAR acuity ≤0.1
between +0.50 and −2.00 D. Similar curves have been
Fig. 6 Patient’ reported incidence of halos and glare, as well as of difficulties when driving at night
Table 3 Previous studies reporting visual outcomes with trifocal intraocular lens
First author
Lens studied
Patients included
Mean age (years)
Mean uncorrected binocular visual acuity (% of patients with uncorrected binocular acuity <0.1)
Far (4 m) Intermediate (60 cm) Near (33 cm)
Garcia-Perez (current study)
PanOptix
58 patients
69.3 ± 9.8
0.03 ± 0.04
(96.6%)
0.12 ± 0.14
(56.9%)
0.02 ± 0.09
(86.2%)
Alfonso [4]
AT LISA tri 839MP
102 patients
60.5 ± 8.5
0.03
(86.1%)
0.11
(28.7%)
0.32a
(0%)
Kohnen [7]
AT LISA tri 839MP
27 patients
64 ± 7.9
- 0.06 ± 0.09 - 0.01 ± 0.10d 0.03 ± 0.11c
Kretz [19]
AT LISA tri 839MP
50 patients
59.3 ± 7.6
0.04
(91%*)
0.04e
(79%*)
0.01c
(87%*)
Mendicute [10]
AT LISA tri 839MP
104 patients (89.3%) (67.7%)d (52%)c
Marques [15]
Finevision Micro F
AT LISA tri 839MP
15 patients
71 ± 7
15 patients
70 ± 5
0.02 ± 0.02
0.00 ± 0.01
0.03 ± 0.054
0.13 ± 0.424
0.02 ± 0.023
0.13 ± 0.053
Cochener [5]
Finevision
99 patients
66.9 ± 9.1
0.01 ± 0.07 0.06 ± 0.08 0.00 ± 0.03a
Jonkers [6]
Finevision
15 patients
62.6 ± 8.7
0.01 ± 0.08 0.33 ± 0.10b 0.11 ± 0.11c
*LogMAR ≤0.00
Distances at which intermediate and near visual acuities were measured that are other than described in the headings are as follows:
a30 cm; b70 cm; c40 cm; d80 cm; e66 cm
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described for other trifocal IOLs [5, 6, 8, 12, 17, 21–24].
Kohnen et al. also evaluated the defocus curve monocularly
for the AT LISATri; visual acuity dropped to approximately
0.2 LogMAR for −1.50 and −2.00 D [7], a slightly worse
result than we found.
Another concern about trifocal technology is whether
light distribution may vary from the optimum in different
luminance levels. We did not find differences in visual
acuities between photopic and mesopic conditions, a fact
that would support that light distribution for the PanOptix
is less dependent on pupillary size. Multifocal IOL design
might also lead to a reduction in contrast sensitivity, since
light from the out-of-focus image reduces the sharpness of
the in-focus image. However, we found that the studied
IOL had very good contrast sensitivity values, with mean
photopic values of 2.05, 1.97, 1.79 and 1.56 for 3, 6, 12
and 18 cpd respectively. There were no significant differ-
ences with mesopic values. Contrast sensitivity was mea-
sured binocularly, in order to better evaluate the impact of
the IOL on a situation more similar to daily life and to fa-
cilitate comparisons with previous studies performed with
other IOLs. Photopic contrast sensitivity values were
slightly better than described for the FineVision (between
1.64 and 1.66 for 3 cpd, 1.71 and 1.77 for 6 cpd, 1.09 and
1.44 for 12 cpd and 0.62 and 0.96 [6, 22, 23]) and for
the ATLISA (1.56, 1.66, 1.37 and 0.94 for 3, 6, 12 and
18 cpd respectively [23]).
As regards patients’ ability to perform daily tasks with-
out spectacle correction, one patient reported using
spectacles occasionally for all distances, one patient
sometimes for far distances and one patient always for
near and far distances. This last patient was an 83-year-
old lady with 1.50D residual astigmatism in her right eye
who did not desire to undergo further surgery to correct
it. Most patients reported no or little difficulty for the
activities included in the Catquest 9-SF questionnaire.
Driving at night was, as expected, the most challenging
activity: 15 patients (25.9%) reported having difficulties
occasionally or often and 1 patient (1.7%) always. Studies
performed with the FineVision IOL have reported that
between 95 and 100% of patients were spectacle-free for
distance and approximately 20% patients needed glasses
for near distance between three and six months after
surgery [5, 6]. Reports on spectacle independence with
the AT LISA Tri are less consistent, with spectacle re-
quirement for near vision ranging between 10 and 30%
[7, 10, 20]. The perception of photic phenomena is al-
most unavoidable with multifocal IOLs. They are re-
ported by up to 90% of patients implanted with trifocal
IOLs, although most describe them as not bothersome
[8, 10]. Furthermore, the perception of photic phenom-
ena decreases with time [8, 17]. In our study, 19 patients
(32.8%) reported seeing halos often or always with low
illumination and 6 patients (10.3%) reported glare.
This study has several limitations. The number of pa-
tients included is relatively low and no comparison was
made with other trifocal IOLs. One month is a short
follow-up period. Patients might experience refractive
changes with time, as well as visual acuity decreases due
to posterior capsule opacification. Longer follow-up
would be necessary to more precisely characterize the
IOLs outcomes. It must also be taken into account that
patients completed the visual satisfaction questionnaire
between nine and 12 months after surgery and therefore
not at the time clinical outcomes were evaluated. This is
another limitation of the study, since for instance photic
phenomena have been described to decrease with time
and neuroadaptation might influence perceived outcomes.
In summary, the present study found that the new
PanOptix trifocal IOL provided good short-term visual
outcomes, with uncorrected monocular and binocular
visual acuities for all distances consistent with those re-
ported for other trifocal IOLs. The defocus curves suggest
that patients will have a satisfactory range of intermediate
vision. Contrast sensitivity was high, suggesting light scat-
tering is low. The fact that there were no differences be-
tween photopic and mesopic conditions for visual acuity
and contrast sensitivity supports the hypothesis that the
IOL is more pupillary-independent. Patient’ reported out-
comes were good as evaluated with the Catquest 9-SF
questionnaire. It remains to be confirmed that visual
outcomes and patient satisfaction remain high with time.
Further studies comparing the different trifocal IOLs,
with a longer follow-up period would be necessary to
better define the ideal IOL for each patient.
Conclusion
The new Panoptix IOL provides good visual acuity out-
comes in daily practice. The trifocal design does not ap-
pear to affect contrast sensitivity and visual function is
similar in different lighting conditions, suggesting a low
pupillary dependence. Patient reported outcomes reveal
that spectacle requirement is low after bilateral im-
plantation with a low incidence of glare and haloes.
Therefore, it represents an option for patients who wish
to be spectacle-free after cataract surgery with a good
range of vision and a low rate of visual disturbances.
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